Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy

BACKGROUND: Between 8% and 22% of female carriers of DMD mutations exhibit clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers without chromosomal rearrangements has been attributed to skewed X-chromosome inactivation (XCI) favouring predominant expression of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Juan-Mateu, Jonàs, Rodríguez, Maria José, Nascimento, Andrés, Jiménez-Mallebrera, Cecilia, González-Quereda, Lidia, Rivas, Eloy, Paradas, Carmen, Madruga, Marcos, Sánchez-Ayaso, Pedro, Jou, Cristina, González-Mera, Laura, Munell, Francina, Roig-Quilis, Manuel, Rabasa, Maria, Hernández-Lain, Aurelio, Díaz-Manera, Jorge, Gallardo, Eduard, Pascual, Jordi, Verdura, Edgard, Colomer, Jaume, Baiget, Montserrat, Olivé, Montse, Gallano, Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492175/
https://www.ncbi.nlm.nih.gov/pubmed/23092449
http://dx.doi.org/10.1186/1750-1172-7-82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492175/
https://www.ncbi.nlm.nih.gov/pubmed/23092449
http://dx.doi.org/10.1186/1750-1172-7-82

Ejemplares similares